PURPOSE: Childhood cancer and its treatment may affect health-related quality of life (HRQoL) in childhood cancer survivors, but population-based studies in young survivors are scarce. We aimed to: (1) compare HRQoL between young survivors and population norms and (2) find factors that influence parent-reported HRQoL in survivors. METHODS: As part of the Swiss Childhood Cancer Survivor Study, a questionnaire was mailed to parents of survivors aged 8-16 years, registered in the Swiss Childhood Cancer Registry, ≥5 years after diagnosis. We used the KIDSCREEN-27 instrument to compare self- and parent-reported HRQoL between survivors (N = 425) and standardized norms in the five dimensions of physical well-being, psychological well-being, autonomy, peers and school environment (mean = 50, SD = 10). We then used multivariable linear regressions to test the influence of socio-demographic and cancer-related factors on HRQoL. RESULTS: Self-reported physical well-being was comparable to norms. Other HRQoL dimensions were higher than norms, with the highest mean = 52.2 (p < 0.001) for school environment. Parent-reported HRQoL in survivors was comparable to population norms; only physical well-being was lower (mean = 47.1, p < 0.001), and school environment was higher (mean = 51.1, p = 0.035). Parent-reported HRQoL was lower for survivors of CNS tumors (physical well-being: β = -5.27, p = 0.007; psychological well-being: β = -4.39, p = 0.044; peers β = -5.17, p = 0.028), survivors of neuroblastoma (psychological well-being β = -5.20, p = 0.047), and survivors who had had a relapse (physical well-being β = -5.41, p = 0.005). CONCLUSIONS: Assessing HRQoL during follow-up care, with a focus on physical well-being, specific diagnoses (e.g., CNS tumor) and late complications (e.g., relapse) might help to early identify problems and offer support to survivors with reduced HRQoL.
PURPOSE: Childhood cancer and its treatment may affect health-related quality of life (HRQoL) in childhood cancer survivors, but population-based studies in young survivors are scarce. We aimed to: (1) compare HRQoL between young survivors and population norms and (2) find factors that influence parent-reported HRQoL in survivors. METHODS: As part of the Swiss Childhood Cancer Survivor Study, a questionnaire was mailed to parents of survivors aged 8-16 years, registered in the Swiss Childhood Cancer Registry, ≥5 years after diagnosis. We used the KIDSCREEN-27 instrument to compare self- and parent-reported HRQoL between survivors (N = 425) and standardized norms in the five dimensions of physical well-being, psychological well-being, autonomy, peers and school environment (mean = 50, SD = 10). We then used multivariable linear regressions to test the influence of socio-demographic and cancer-related factors on HRQoL. RESULTS: Self-reported physical well-being was comparable to norms. Other HRQoL dimensions were higher than norms, with the highest mean = 52.2 (p < 0.001) for school environment. Parent-reported HRQoL in survivors was comparable to population norms; only physical well-being was lower (mean = 47.1, p < 0.001), and school environment was higher (mean = 51.1, p = 0.035). Parent-reported HRQoL was lower for survivors of CNS tumors (physical well-being: β = -5.27, p = 0.007; psychological well-being: β = -4.39, p = 0.044; peers β = -5.17, p = 0.028), survivors of neuroblastoma (psychological well-being β = -5.20, p = 0.047), and survivors who had had a relapse (physical well-being β = -5.41, p = 0.005). CONCLUSIONS: Assessing HRQoL during follow-up care, with a focus on physical well-being, specific diagnoses (e.g., CNS tumor) and late complications (e.g., relapse) might help to early identify problems and offer support to survivors with reduced HRQoL.
Authors: V Engelen; H M Koopman; S B Detmar; H Raat; M D van de Wetering; P Brons; J K Anninga; F Abbink; M A Grootenhuis Journal: Pediatr Blood Cancer Date: 2010-12-22 Impact factor: 3.167
Authors: Gemma Gatta; Giulia Zigon; Riccardo Capocaccia; Jan Willem Coebergh; Emmanuel Desandes; Peter Kaatsch; Guido Pastore; Rafael Peris-Bonet; Charles A Stiller Journal: Eur J Cancer Date: 2009-02-21 Impact factor: 9.162
Authors: Myung Ah Rhee; Kyong Mee Chung; Yuri Lee; Hana K Choi; Jung Woo Han; Hyo Sun Kim; Sun Hee Kim; Yoon Jung Shin; Chuhl Joo Lyu Journal: Qual Life Res Date: 2014-05-11 Impact factor: 4.147
Authors: M M Hawkins; E R Lancashire; D L Winter; C Frobisher; R C Reulen; A J Taylor; M C G Stevens; M Jenney Journal: Pediatr Blood Cancer Date: 2008-05 Impact factor: 3.167
Authors: Corina S Rueegg; Micol E Gianinazzi; Johannes Rischewski; Maja Beck Popovic; Nicolas X von der Weid; Gisela Michel; Claudia E Kuehni Journal: J Cancer Surviv Date: 2013-06-20 Impact factor: 4.442
Authors: Melissa M Hudson; Ann C Mertens; Yutaka Yasui; Wendy Hobbie; Hegang Chen; James G Gurney; Mark Yeazel; Christopher J Recklitis; Neyssa Marina; Leslie R Robison; Kevin C Oeffinger Journal: JAMA Date: 2003-09-24 Impact factor: 157.335
Authors: Jennifer van Dijk; Jaap Huisman; Annette C Moll; Antoinette Y N Schouten-van Meeteren; Pieter D Bezemer; Peter J Ringens; Peggy T Cohen-Kettenis; Saskia M Imhof Journal: Health Qual Life Outcomes Date: 2007-12-03 Impact factor: 3.186
Authors: Valentin Benzing; Valerie Siegwart; Janine Spitzhüttl; Jürg Schmid; Michael Grotzer; Claudia M Roebers; Maja Steinlin; Kurt Leibundgut; Regula Everts; Mirko Schmidt Journal: Cancer Med Date: 2021-02-01 Impact factor: 4.452
Authors: Lisa Ljungman; Tiina Remes; Elisabeth Westin; Alina Huittinen; Tuula Lönnqvist; Kirsti Sirkiä; Heikki Rantala; Marja Ojaniemi; Marika Harila; Päivi Lähteenmäki; Pekka Arikoski; Anna Wikman; Arja Harila-Saari Journal: Support Care Cancer Date: 2022-03-03 Impact factor: 3.359